Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity-Reference-Cited by-同舟云学术

Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity

Published:2018-11-13 Issue:5 Volume:115 Page:960-965
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Zhu Wuqiang¹,Reuter Sean¹,Field Loren J¹

Affiliation:

1. The Krannert Institute of Cardiology and the Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 West Walnut Street, R4 Building Room W376, Indianapolis, IN, USA

Funder

National Institutes of Health

American Cancer Society

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/115/5/960/28324873/cvy273.pdf

Reference30 articles.

1. Clinical spectrum of anthracycline antibiotic cardiotoxicity;Bristow;Cancer Treat Rep,1978

2. A clinicopathologic analysis of adriamycin cardiotoxicity;Lefrak;Cancer,1973

3. Anthracycline associated cardiotoxicity in survivors of childhood cancer;Lipshultz;Heart,2008

4. Doxorubicin-induced cardiomyopathy;Singal;N Engl J Med,1998

5. Doxorubicin cardiomyopathy;Chatterjee;Cardiology,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice;Circulation Research;2024-09-13

2. Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms;Frontiers in Pharmacology;2024-05-30

3. CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs;Circulation Research;2023-09

4. Musings on intrinsic cardiomyocyte cell cycle activity and myocardial regeneration;Journal of Molecular and Cellular Cardiology;2023-09

5. Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice;Pharmaceuticals;2023-08-28